Q3 2024 13F Holders as of 30 Sep 2024
-
Type / Class
-
Equity / Common Stock, $0.0001 Par Value
-
Shares outstanding
-
83,070,866
-
Total 13F shares
-
7,681,837
-
Share change
-
+1,824,592
-
Total reported value
-
$17,203,634
-
Put/Call ratio
-
27%
-
Price per share
-
$2.24
-
Number of holders
-
45
-
Value change
-
+$4,113,873
-
Number of buys
-
28
-
Number of sells
-
10
Institutional Holders of Checkpoint Therapeutics, Inc. - Common Stock, $0.0001 Par Value (CKPT) as of Q3 2024
As of 30 Sep 2024,
Checkpoint Therapeutics, Inc. - Common Stock, $0.0001 Par Value (CKPT) was held by
45 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
7,681,837 shares.
The largest 10 holders included
ARMISTICE CAPITAL, LLC, VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, BlackRock, Inc., PVG ASSET MANAGEMENT CORP, WEALTH ENHANCEMENT ADVISORY SERVICES, LLC, MORGAN STANLEY, STATE STREET CORP, SUSQUEHANNA INTERNATIONAL GROUP, LLP, and RENAISSANCE TECHNOLOGIES LLC.
This page lists
46
institutional shareholders reporting positions in this security
for the Q3 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.